Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAR002 in Participants With Acromegaly (TROUGH-2)
NCT07641179Phase 2Recruiting
- Sponsor
- Marea Therapeutics
- Start
- Jul 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 2 trial of MAR002 in acromegaly, sponsored by Marea Therapeutics. Started Jul 2026; status: recruiting.
02
Drugs
MAR002
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT07641179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07641179.